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Innate lymphoid cells (ILCs) have emerged as impor-
tant players, regulating the balance between protec-
tive immunity and immunopathology at mucosal
surfaces. However, mechanisms that regulate ILCs’
effector functions during mucosal pathogenic chal-
lenge are poorly defined. Using mice infected with
the natural mouse enteric pathogen Citrobacter
rodentium, we demonstrate that lymphotoxin (LT) is
essential for IL-22 production by intestinal ILCs.
Blocking of LTbR signaling dramatically reduced
intestinal IL-22 production after C. rodentium infec-
tion. Conversely, stimulating LTbR signaling induced
an IL-22 protection pathway in LT-deficient mice.
Furthermore, exogenous IL-22 expression rescued
LTbR-deficient mice. IL-22-producing ILCs were
predominantly located in lymphoid follicles in the
colon and interacted closely with dendritic cells
(DCs). We find that an LT-driven positive feedback
loop controls IL-22 production by RORgt+ ILCs via
LTbR signaling in DCs. Taken together, our data
show that LTbR signaling in gut lymphoid follicles
regulates IL-22 production by ILCs in response to
mucosal pathogen challenge.
INTRODUCTION
Innate lymphoid cells (ILCs) represent a heterogeneous popula-
tion of innate lymphocytes in themucosa that participate in regu-
lation of mucosal immune homeostasis (Colonna, 2009; Sawa
et al., 2010; Spits and Di Santo, 2011). Although ILCs do not
express antigen-specific receptors like adaptive lymphocytes,
they have the capacity to produce, upon stimulation, several
cytokines that function to regulate the balance between protec-
tive immunity and destructive inflammation in the gut. However,
the pathways that mediate crosstalk between ILCs and intestinal
epithelial cells in response to mucosal bacterial infection remain44 Cell Host & Microbe 10, 44–53, July 21, 2011 ª2011 Elsevier Inc.poorly understood. Citrobacter rodentium is a natural mouse
extracellular enteric pathogen that mimics human enteropatho-
genic Escherichia coli and enterohaemorrhagic E. coli infections
(Mundy et al., 2005). C. rodentium uses attaching and effacing
lesion formation as a major mechanism to target and infect the
intestinal epithelial layer and, therefore, represents an excellent
model to define the role of ILCs in intestinal immunehomeostasis.
Lymphoid tissue inducer (LTi) cells belong to ILCs and are
critical for development of secondary lymphoid tissues during
fetal development (Eberl et al., 2004; Randall et al., 2008; Roo-
zendaal and Mebius, 2011; Spits and Di Santo, 2011). However,
their role in regulation of mucosal immune responses in the gut is
poorly defined. Recently, a CD4+ population of LTi cells within
the intraepithelial lymphocyte (IEL) compartment has been impli-
cated in controlling mucosal bacterial infection (Sonnenberg
et al., 2011b). Another ILC subset that expressed the NK cell
marker NKp46 and is located in small and large intestine lamina
propria has also been suggested to control C. rodentium infec-
tion (Cella et al., 2009; Satoh-Takayama et al., 2008). Both the in-
traepithelial LTi cells and the lamina propria NKp46+ cells, aswell
as other ILCs in the gut, express retinoic acid receptor (RAR)-
related orphan receptor gamma t (RORgt), which is required
for their development (Colonna, 2009; Eberl et al., 2004; Spits
and Di Santo, 2011).
Recent studies have suggested that development of LTi cells
and mucosal NKp46+ cells is distinct from classical NK cells
(Colonna, 2009; Spits and Di Santo, 2011). The developmental
relationship between NKp46+ and LTi cells remains an active
area of research. Several studies suggested that RORgt+NKp46+
cells canoriginate fromRORgt+ LTi cells (Cupedoet al., 2009; Vo-
narbourg et al., 2010). However, another report indicated distinct
developmental programs of these populations, originally gener-
ated from a common fetal liver progenitor (Sawa et al., 2010). In
contrast to LTi cells, NKp46+ cells require commensal microflora
for their development (Sanos et al., 2009; Satoh-Takayama et al.,
2008). However, this requirement has not been confirmed by
other studies (Sawa et al., 2010; Sawa et al., 2011). Additionally,
inactivation of the Ncr1 gene (encoding NKp46) did not impact
susceptibility to C. rodentium infection (Satoh-Takayama et al.,
2009). Hence, the underlying function of mucosal NKp46+ cells
in innate immune response is currently unclear.
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Figure 1. LTbR Signaling Controls the
Innate IL-22 Pathway in the Gut
(A) IL-22 levels in the colon of naive and infected
WT and Ltbr/mice. LTbr/ andWTmice (n = 5/
group/experiment) were orally inoculated with
C. rodentium. mRNA expression of IL-22 and
IL-22- dependent RegIIIg and RegIIIb antimicro-
bial proteins in the colon were measured by real-
time PCR on day five postinfection. Naive mice
were used as control.
(B)WTmicewere treatedwith 150mgof LTbR-Ig, or
control human Ig (hIg) at day zero and three post-
infection. Expression of IL-22 and RegIIIg and
RegIIIb antimicrobial proteins were measured in
the colon by real-time PCR at day five post-
infection.
(C) Rag1/ mice were treated intraperitoneally
with 150 mg of LTbR-Ig at day zero and three
postinfection, and expression of IL-22, and RegIIIg
and RegIIIb antimicrobial proteins was measured
by real-time PCR at day five postinfection. (All
panels) Data represent means ± SEM. n = 5, *p <
0.05, **p < 0.01. Data represent one of three inde-
pendent experiments with similar results. Real-
timePCRdatawere normalized to hprt expression.
Cell Host & Microbe
LTbR Controls IL-22 Protection Pathway in the GutThe major functions of ILCs in mucosal immunity against
C. rodentium infection, as well as epithelial tissue repair, are
potentially mediated by the production of the cytokine IL-22
(Cella et al., 2009; Luci et al., 2009; Sanos et al., 2009; Satoh-Ta-
kayama et al., 2008). IL-22 is a recently discovered cytokine of
the extended IL-10 family that plays multiple roles in the regula-
tion of mucosal immunity (Ouyang, 2010; Ouyang et al., 2011;
Sonnenberg et al., 2011a). IL-22 signals through the IL-22R
that is selectively expressed by intestinal epithelial cells. IL-22
can induce secretion of antimicrobial proteins from these epithe-
lial cells, including RegIIIg and RegIIIb, to kill C. rodentium
(Zheng et al., 2008). Accordingly, IL-22-deficient mice show
increased morbidity and mortality after C. rodentium infection
(Zheng et al., 2008). IL-23 has been shown to promote IL-22
production (Sonnenberg et al., 2011b; Zheng et al., 2008).
Furthermore, IL-23-deficient mice display reduced IL-22 levels
and succumb to C. rodentium infection (Zheng et al., 2008).
However, other potential regulators of IL-22 production by
ILCs remain poorly understood.
Lymphotoxin (LT) is amember of the TNF core family and plays
a critical role in the regulation of mucosal immune responses (Fu
and Chaplin, 1999; Tumanov et al., 2007; Ware, 2005). The bio-
logically active form of surface LT presents as a heterotrimeric
complex (LTb2LTa1) that interacts specifically with LTbR. While
LT is expressed mostly by lymphocytes, including T, B, NK,
and LTi cells, LTbR is expressed in DCs and stromal, epithelial,
and myeloid cells, but not on lymphocytes (Fu and Chaplin,
1999; Tumanov et al., 2007; Ware, 2005). LTbR signaling inCell Host & Microbe 10, 4DCs regulates DC homeostasis (Kaba-
shima et al., 2005; Summers Deluca
and Gommerman, 2011). Evidence of
crosstalk between LT-expressing T cells
and LTbR-bearing DCs promotes T cell
responses to a model antigen in mice
(Summers-DeLuca et al., 2007; SummersDeluca and Gommerman, 2011). However, the role of LT in
crosstalk between lymphocytes and DCs in host defense and
autoimmune diseases remains to be fully elucidated. LTbR
signaling plays a critical role in host defense againstC. rodentium
infection (Spahn et al., 2004), as all LTbR-deficient mice
succumb early to C. rodentium infection (Spahn et al., 2004;
Wang et al., 2010). In the present study, we explore the relation-
ship between IL-22 and the LTbR pathway and determine that
LTbR signaling controls the IL-22 protective pathway in the gut
via coordination of RORgt+ ILCs with DCs in lymphoid follicles.
RESULTS
LTbR Signaling Controls Innate IL-22 Pathway in the Gut
IL-22 is essential for control of earlyC. rodentium infection (Zheng
et al., 2008). Since LTbR-deficient mice also succumb early to
C. rodentium infection, we speculated that LTbR signaling might
regulate IL-22 production. To test this hypothesis, we measured
IL-22 levels in the colon ofWTandLTbR-deficientmice early after
C. rodentium infection. Compared to WT mice, expression of
IL-22 was dramatically reduced in the colon of Ltbr/mice (Fig-
ure 1A). mRNA expression of IL-22-dependent antimicrobial
proteins RegIIIg and RegIIIb was also reduced in the colon of
Ltbr/ mice at day five postinfection (Figure 1A). In contrast to
infected mice, basal IL-22 levels were comparable in the colon
of naive WT and Ltbr/mice (Figure 1A). These results suggest
the critical role of LTbRsignaling in controlling IL-22 production in
the gut in response to mucosal bacterial infection.4–53, July 21, 2011 ª2011 Elsevier Inc. 45
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Figure 2. IL-22 Is an Essential Protection
Pathway Downstream of LTbR Signaling
(A–C) Stimulation of LTbR signaling promotes the
IL-22 protection pathway. Ltb/ mice were in-
jected intraperitoneally with 75 mg of agonistic anti-
LTbR antibody or control rat Ig (rIg) at day zero and
three postinfection with C. rodentium. mRNA
expression of IL-22 (A) and RegIIIg (B) were
measured in the colon by real-time PCR at day four
postinfection. Bacterial titers in liver are shown at
day four postinfection (C). n = 4, **p < 0.01. Data
represent means ± SEM.
(D–G) Hydrodynamic injection of IL-22-expressing
plasmid rescues Ltbr/ mice from lethal
C. rodentium infection. IL-22-expressing plasmid or
control vector was intravenously injected to WT or
Ltbr/ mice 6 hr after C. rodentium infection. n =
10–13/group. Survival (D) and body weight change
(E) are shown. ***p < 0.001 between IL-22-treated
Ltbr/ and control untreated Ltbr/ mice by
Mantel-Cox log rank test. Data combined from two
experiments with similar results. Representative
hematoxylin and eosin staining of colons is shown
at day nine postinfection (F). Red boxes in top
panels are shown at higher magnification in lower
panels. Bars: 1 mm for top panels and 200 mm for
lower panels. Colitis histopathology score (G). n = 5,
*p < 0.05. Data represent means ± SEM.
Cell Host & Microbe
LTbR Controls IL-22 Protection Pathway in the GutLTbR-deficient mice display multiple immune abnormalities,
including lack of lymph nodes and gut-associated lymphoid
tissues, defects in DC and NK cell development and IgA produc-
tion, and defects in central tolerance (Zhu et al., 2010). Therefore,
in order to exclude developmental defects in Ltbr/ mice that
might affect IL-22 production in the gut, we treatedWTmice early
after infection with soluble LTbR-Ig fusion protein, which tran-
siently blocks LTbR signaling. WT mice treated with LTbR-Ig at
days one and three after infection showed severe pathology,
and around 50% of LTbR-Ig-treated mice died after acute infec-
tion, consistent with previous reports (Wang et al., 2010).
Remarkably, expression of IL-22 and IL-22-dependent antimi-
crobial proteins was severely reduced in the colon of LTbR-Ig-
treated mice at day five postinfection, compared to control
mice (Figure 1B). These results suggest that LTbR signaling at
the time of infection is required for IL-22 induction in the gut.
To further define whether LTbR signaling regulates innate
mechanisms of IL-22 production, we treated Rag1-deficient
mice with LTbR-Ig. This treatment reduced expression of both
IL-22 and antimicrobial proteins in the colon (Figure 1C), indi-
cating the critical role of LTbR in controlling IL-22 production
by ILCs. LTbR is known to regulate expression of several
chemokines and adhesion molecules responsible for migration
of lymphoid cells to the gut (Fu and Chaplin, 1999; Ware,
2005). Therefore, impaired migration or development of IL-22-
producing cells could result in reduced IL-22 levels in the gut.46 Cell Host & Microbe 10, 44–53, July 21, 2011 ª2011 Elsevier Inc.However, analysis of gut lymphoid cells re-
vealed similar numbers of innate cell pop-
ulations within the colon of WT and Ltbr/
mice (Figure S1). These results suggest
that the defect in IL-22 production in
LTbR-deficient mice is not due to theabsence of innate cells capable of producing IL-22 in the gut.
In fact, lamina propria lymphocytes from Ltbr/ mice were
capable of producing IL-22 after IL-23 stimulation in vitro
(Figures S1C and S1D), suggesting no intrinsic defect in produc-
tion of IL-22 by these cells. Thus, our data demonstrate that
direct LTbR signaling is essential for control of the innate IL-22
pathway in the gut after mucosal bacterial infection.
IL-22 Is an Essential Protection Pathway Downstream
of LTbR Signaling
Surface LT and LIGHT (TNFSF14) are two known ligands for
LTbR (Fu and Chaplin, 1999; Ware, 2005). To determine whether
LIGHT or LT controls IL-22 production in the gut after infection,
we orally infected WT, LTb- and LIGHT-deficient mice with
C. rodentium. Clearly, IL-22 expression was reduced in the colon
of Ltb/ (Figure S2A), but not in Tnfsf14/ mice (Figure S2D),
suggesting the essential role of surface LT in controlling IL-22
production after infection. Expression of LT in adaptive immune
cells was dispensable for IL-22 production, because mice that
lack surface LT specifically on T and B cells (T,B-Ltb/) were
able to express similar mRNA levels of IL-22 and antimicrobial
proteins RegIIIg andRegIIIb compared toWTmice after infection
(Figures S2A–S2C). Consistently, Tnfsf14/ mice and T,B-Ltb/
mice survived C. rodentium infection (Wang et al., 2010). To
determine whether LTbR signaling is sufficient to induce IL-22
production in the gut, we treated LT-deficientmicewith agonistic
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Figure 3. IL-22 Is Produced in Lymphoid Follicles
by Innate RORgt+ Cells
(A) IL-22 is predominantly expressed in the lamina propria.
Colon lamina propria (LP) and intraepithelial lymphocyte
(IEL) cell populations from WT mice were purified at day
five postinfection. IL-22 expression wasmeasured by real-
time PCR. Data were normalized to hprt expression. Data
represent means ± SEM. n = 5 mice, **p < 0.01.
(B) LTi cells are predominant IL-22-producing cells in the
lamina propria. Colon LP innate cell populations from
RORgt-GFP+//Ltbr+/+ and RORgt-GFP+//LTbr/ mice
at day five postinfection were purified by flow cytometry.
IL-22 expression was measured by real-time PCR. Sorted
cell populations are indicated as LTi: CD45+CD3GFP+
NK1.1NKp46; NKp46: CD45+CD3GFP+NKp46+; NK:
CD45+CD3GFPNK1.1+; and Th17: CD45+CD3+GFP+
NK1.1NKp46. Data were combined from two experi-
ments and represent means ± SEM. n = 4, **p < 0.01. IL-22
data were normalized to hprt expression.
(C) IL-22-expressing cells are predominantly located in
lymphoid follicles. WT mice were orally infected with
C. rodentium, and colon sections at day five postinfection
were stained with indicated antibodies. Nuclei were
stained with DAPI. Bars: 20 mm.
(D) IL-22-producing cells interact with DC in lymphoid
follicles. Colon sections of mice at day five postinfection
were stained with indicated antibodies and analyzed by
confocal microscopy. Nuclei were stained with DAPI.
Arrows indicate contact of DC (green) with IL-22-
producing cells (red) on top panel and RORgt+CD4 cells
on bottom panel. Bars: 10 mm.
(E) IL-22 is expressed predominantly in isolated lymphoid
follicles. WT mice were orally infected with C. rodentium,
and colon tissue was collected at day five postinfection.
Isolated lymphoid follicles (ILF+) and surrounding tissue
(ILF) were microdissected under stereo microscope, and
IL-22 expression was measured by real-time PCR. IL-22 data were normalized to hprt expression. *p < 0.05, n = 3 mice, means ± SEM.
(F) Coculture of LTi cells with DC promotes IL-22 production by LTi cells. Lamina propria LTi cells from naive RORgt-GFP+/mice were cocultured in vitro for 18 hr
with lamina propria DCs fromWTmice at day five postinfection. After coculture, LTi and DC cells were separated by flow cytometry, and IL-22 was measured by
real-time PCR. Data were normalized to b-actin. One of two independent experiments with similar results is shown.
Cell Host & Microbe
LTbR Controls IL-22 Protection Pathway in the Gutanti-LTbR antibody. We found that anti-LTbR treatment greatly
induced expression of IL-22 in the colon early after infection (Fig-
ure 2A), increased production of antimicrobial proteins (Fig-
ure 2B), and reduced bacterial dissemination into peripheral
organs (Figure 2C). These results suggest that LTbR signaling
is sufficient to promote the IL-22 pathway following mucosal
bacterial infection in vivo. However, it was not clear whether
IL-22 is the essential protection pathway downstream of LTbR
signaling, because LTbR could regulate other protection mech-
anisms. To address this question, we tested whether Ltbr/
mice could be rescued from lethal C. rodentium infection by
using hydrodynamic IL-22 injection. Remarkably, a single IL-22
injection 6 hr after infection was able to rescue Ltbr/ mice
from an otherwise lethal C. rodentium infection. More than
60% of Ltbr/ mice treated with IL-22 survived the infection
(Figures 2D and 2E). Ltbr/ mice treated with control vector
showed severe colon inflammation, loss of goblet cells, and
ulcerations of the epithelial layer, and they developed severe
diarrhea and all died by day 12 postinfection (Figures 2D–2G).
In contrast, histological analysis of colon sections of IL-22-
treated Ltbr/ mice at day nine postinfection revealed reduced
colon inflammation and reduced histopathology scores (Figures
2F and 2G). These data suggest that IL-22 is an essentialCpathway downstream of LTbR signaling to protect mice against
mucosal bacterial pathogens.
IL-22 Is Produced in Lymphoid Follicles by Innate
RORgt+ Cells
Our data suggested that LTbR signaling controls the innate IL-22
production in response to mucosal bacterial infection. However,
the innate cell populations that are regulated by LTbR signaling
remained unclear. Analysis of IL-22 expression in total cell pop-
ulations from the colon revealed predominant expression of
IL-22 in lamina propria lymphocytes (LPLs), compared to IELs
(Figure 3A). To further define the innate cell source of IL-22, we
next measured expression of IL-22 in purified innate cell popula-
tions from lamina propria after infection. Because all ILCs require
the transcriptional factor RORgt for their development (Eberl
et al., 2004; Spits and Di Santo, 2011), we utilized RORgt-
GFP+/ reporter mice that are heterozygous for insertion of
a green fluorescent protein (GFP) reporter into the Rorc gene
(Eberl and Littman, 2004) to determine IL-22 expression from
the sorted cells. We found that LTi cells were the predominant
IL-22-producing population in the lamina propria (Figures 3B
and S3). Furthermore, we crossed Ltbr/ mice to RORgt-
GFP+/ reporter mice to allow isolation of RORgt+ ILCs fromell Host & Microbe 10, 44–53, July 21, 2011 ª2011 Elsevier Inc. 47
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Figure 4. LT Expression in RORgt+ Cells Is
Essential for Control of IL-22 Production and
Protection of Mice against C. rodentium Infection
(A and B) LT expression in RORgt+ cells controls the IL-22
protection pathway. WT and RORgt-Ltb/ mice were
orally infected with C. rodentium. Expression of IL-22 in
colon and purified lamina propria cells (A) and in antimi-
crobial proteins RegIIIg and RegIIIb (B) was measured by
real-time PCR at day five postinfection. Data represent
means ± SEM. One out of three independent experiments
with similar results is shown. n = 5 mice, *p < 0.05, **p <
0.01. Expression data were normalized to hprt expression.
(C) IL-22 expression is sufficient to rescue RORgt-Ltb/
mice from lethal C. rodentium infection. WT and RORgt-
Ltb/ mice were intravenously injected with IL-22-
expressing plasmid or control vector at 6 hr after
C. rodentium infection. n = 10/group. Data were combined
from two experiments with similar results. Survival and
body weight change are shown.
(D) Representative hematoxylin and eosin staining of the
colon at day nine postinfection. Red boxes in top panel are
shown at higher magnification in lower panel. Bars: 1 mm
for top panel and 200 mm for lower panel.
(E) Colitis histopathology score for mice in panel (A). n = 5,
***p < 0.001. Data represent means ± SEM. One of two
experiments with similar results is shown.
Cell Host & Microbe
LTbR Controls IL-22 Protection Pathway in the GutLTbR-deficient mice by flow cytometry. Expression of IL-22 was
greatly reduced in LTi cells from RORgt-GFP+//Ltbr/ mice,
compared to RORgt-GFP+//Ltbr+/+ control mice (Figure 3B),
suggesting that, in the absence of LTbR signaling, the LTi cells
are unable to produce IL-22 after infection.
To better define the location of IL-22-producing cells in the
gut, we stained colon sections with anti-IL-22 antibody at day
five postinfection. Surprisingly, most of the IL-22-expressing
cells were not randomly scattered in lamina propria, but were
predominantly located in isolated lymphoid follicles (ILFs) and
colonic patches (Figures 3C and 3D). Consistently, we found
predominant IL-22 expression in ILF-containing areas microdis-
sected from colon tissue, compared to ILF-negative areas (Fig-
ure 3E). Although the DCs concentrated in B cell areas, they48 Cell Host & Microbe 10, 44–53, July 21, 2011 ª2011 Elsevier Inc.did not produce IL-22. However, we observed
that they were in close contact with RORgt+
IL-22-producing cells (Figures 3C and 3D).
Furthermore, colon lamina propria DCs purified
from infected mice were able to activate naive
LTi cells to produce IL-22 when cocultured
in vitro (Figure 3F), suggesting that cooperation
of DC and LTi cells promotes efficient IL-22
production after infection. Thus, our results
suggest that IL-22 is produced predominantly
by innate RORgt+ cells that are located within
gut-associated lymphoid tissues.
LT Expression in RORgt+ Cells Is Essential
for Control of IL-22 Production
and Protection of Mice against
C. rodentium Infection
Since our data suggested the critical role of
LTbR signaling in controlling the innate IL-22pathway, we next tested whether LT expression in innate
RORgt+ cells is essential for IL-22 production. In order to test
this, we utilized mice with specific inactivation of surface
LTb2LTa1 complex on RORgt
+-expressing cells (RORgt-Ltb/
mice), by crossing LTb floxed mice (Tumanov et al., 2002)
with RORgt-Cre transgenic mice (Eberl et al., 2004). We found
that IL-22 expression in colon tissue or in colon lamina propria
cells was dramatically reduced in RORgt-Ltb/ mice,
compared to WT mice (Figure 4A). Reduced expression of
IL-22 in the colon correlated with reduced expression of
IL-22-dependent antimicrobial proteins RegIIIg and RegIIIb
(Figure 4B). Thus, our data suggest that surface LT expression
in RORgt+ cells is essential to controlling the IL-22 production
in the gut.
Cell Host & Microbe
LTbR Controls IL-22 Protection Pathway in the GutTo determine whether the IL-22 pathway is an essential
protectionmechanism downstream of LT signaling, we delivered
exogenous IL-22 by hydrodynamic injection of IL-22-expressing
plasmid to RORgt-Ltb/ mice. Exogenous IL-22 rescued
RORgt-Ltb/mice, as 90% of mice treated with IL-22 survived
the infection and did not lose weight, compared to mice treated
with control vector (Figure 4C). RORgt-Ltb/ mice rescued
by IL-22 delivery showed reduced colonic inflammation and
bacterial dissemination to peripheral organs, compared to
RORgt-Ltb/ mice treated with control vector (Figures 4D and
4E). Thus, LT expression in innate RORgt+ cells is essential to
controlling the IL-22 protective pathway.
LTbR Signaling on DCs Is Required for IL-22 Production
Our results suggested that LT expression directly regulates
IL-22 production from RORgt+ cells. Therefore, we considered
two potential mechanisms to explain how LT regulates IL-22
production. We first considered that direct interactions among
innate RORgt+ cells expressing both surface LT and LTbR
lead to IL-22 production. We also considered an indirect mech-
anism, where RORgt+ cells produce IL-22 via interaction with
accessory LTbR-expressing cells. To test these possibilities,
we used a conditional gene targeting approach by inactivating
ltbr in different cell types. We first ruled out the direct mecha-
nism, because mice with specific inactivation of ltbr in RORgt+
cells produced similar levels of IL-22 and antimicrobial proteins
after infection, compared to WT mice (Figure S4). Since our data
showed a close interaction of RORgt+ cells with DCs in
lymphoid follicles, we proposed that LT signaling by RORgt+
cells could trigger LTbR on DCs to provide additional signals
for IL-22 production by RORgt+ cells, as a positive feedback
loop mechanism. In order to resolve this hypothesis, we inacti-
vated the ltbr gene specifically in DCs by crossing LTbR floxed
mice (Wang et al., 2010) with CD11c-Cre transgenic mice
(Stranges et al., 2007), generating CD11c-Ltbr/ mice. We
found an efficient deletion of the ltbr gene and mRNA in bone
marrow-derived DCs from CD11c-Ltbr/ mice (Figures S5A
and S5B). Since CD11c is also expressed at lower levels in
NK cells (Laouar et al., 2005; Stranges et al., 2007), we cannot
exclude the possibility of ltbr gene deletion in a fraction of NK
cells. However, CD11c-Cre expression is unlikely to affect the
development or function of NK cells, since the number of
NKp46+ and LTi cells was not affected in CD11c-Ltbr/ mice
(Figure S5C and data not shown). CD11c-Ltbr/ mice
infected with C. rodentium showed significant reduction of
body weight compared to WT mice, but were able to survive
infection (Figure 5A). CD11c-Ltbr/ mice showed focal colon
bacterial lesions in the colon (Figure 5B) and were not able to
control bacterial dissemination to peripheral organs (Figures
5C–5E). These data suggest that LTbR signaling in DCs is
required for efficient immune response to mucosal pathogens.
To define whether LTbR signaling on DCs is required for IL-22
production, we measured IL-22 production in the colon of
CD11c-Ltbr/ mice early after infection. We found that both
IL-22 mRNA and protein expression were greatly reduced in
the colon of CD11c-Ltbr/mice compared to WT mice (Figures
5F and 5G). Consistently, expression of IL-22-dependent anti-
microbial protein RegIIIg was reduced in the colon of CD11c-
Ltbr/ mice (Figure 5H). These results suggest that LTbRCsignaling in DCs is required for effective IL-22 production in
the gut postinfection.
To further define the mechanism of IL-22 production by LTi
cells, we measured expression of cytokines in colon lamina
propria DCs isolated from WT and Ltbr/ mice at day five
postinfection. We found that expression of IL-23, a potent
inducer of IL-22 (Sonnenberg et al., 2011b; Zheng et al.,
2008), was reduced in DCs purified from the colon of Ltbr/
mice, compared to WT mice (Figure 5I). In contrast to IL-23
expression, DCs from WT and Ltbr/ mice expressed similar
levels of IL-1b and IL-6 (Figure 5I). These results suggest that
LTbR signaling activates the IL-22 pathway indirectly via IL-23
production by DCs.
DISCUSSION
ILCs regulate the immune response to pathogens at mucosal
barriers. However, the mechanism that controls their effector
functions is not well defined. In this study, we identified LTbR
signaling as an essential regulator of the IL-22 protection
pathway in the gut. We demonstrate that LT controls IL-22
production by ILCs in response to the enteric bacterial pathogen
C. rodentium. LT from innate RORgt+ cells, but not from adap-
tive T or B cells, was essential for IL-22 production. IL-22-
producing RORgt+ cells localized predominantly in gut B cell
follicles and interacted closely with DCs. We demonstrate that
LT controls IL-22 production by RORgt+ ILCs indirectly via
LTbR signaling in DCs. Therefore, LT represents a regulator of
the IL-22 protection pathway, via ILCs, to control mucosal
bacterial infection.
Previous studies identified IL-22 as a critical cytokine in
controlling C. rodentium infection (Zheng et al., 2008). This
IL-22 protective effect is mediated via production of antimicro-
bial proteins by epithelial cells that specifically express IL-22R.
Additionally, IL-22R signaling is required for survival and regen-
eration of intestinal epithelial cells after injury, as well as for
mucus production (Sugimoto et al., 2008; Zenewicz et al.,
2008). Innate immune cells are critical for production of this
IL-22 that provides host protection after enteric C. rodentium
infection (Zheng et al., 2008). IL-23 was shown as a critical
regulator promoting IL-22 production by ILC in vitro and
in vivo (Sonnenberg et al., 2011b; Zheng et al., 2008). However,
other pathways that influence IL-22 production remained largely
unknown. Our data show that the LTbR pathway is an essential
regulator of IL-22 production by innate immune cells in response
to enteric bacterial infection. Since LTbR-deficient mice display
multiple defects in components of both the innate and adaptive
immune system, it is important to define whether the IL-22
pathway is an essential LTbR-dependent mechanism that might
impart protection against C. rodentium. By using both agonistic
anti-LTbR stimulation in LT-deficient mice and reconstitution
of IL-22 expression in LTbR-deficient mice, we demonstrate
that IL-22 is a critical protection pathway downstream of LTbR
signaling.
Our next experiments aimed to determine which LT-express-
ing cell populations are essential for IL-22 production after infec-
tion. Our results suggest that LT expression by innate, but not
adaptive, immune cells is critical for IL-22 production and host
protection, because mice with specific inactivation of surfaceell Host & Microbe 10, 44–53, July 21, 2011 ª2011 Elsevier Inc. 49
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Figure 5. LTbR Signaling in DCs Is Required
for IL-22 Production
(A and B) WT, CD11c-Ltbr/, and Ltbr/ mice
were orally infected with C. rodentium. Body
weight change (A) and representative hematoxylin
and eosin staining of colon at day 12 postinfection
(B) are shown. Arrows indicate bacterial lesions.
Bars: 50 mm (top panels) and 20 mm (lower panels).
(C–H) Bacterial titers were measured in feces (C)
on day 14 and in liver (D) and spleen (E) on day 10
postinfection. Data represent IL-22 expression in
the colon (F), IL-22 levels in colon supernatants
(G), and expression of RegIIIg mRNA in the colon
(H), all at day five postinfection. Data represent
means ± SEM. n = 5 mice, *p < 0.05, **p < 0.01.
One of three independent experiments with similar
results is shown. Real-time PCR data were
normalized to hprt expression.
(I) LTbR signaling in DCs regulates IL-23 produc-
tion. CD11c+CD11b+ DCs from colon lamina
propria of WT and LTbr/ mice were purified by
flow cytometry at day five postinfection. Expres-
sion of IL23p19, IL23p40, IL-1b, IL-6 cytokines
was measured by real-time PCR. Data were
combined from two experiments and represent
means ± SEM. n = 4, *p < 0.05. ‘‘NS’’: not
significant. RT-PCR data were normalized to hprt
expression.
Cell Host & Microbe
LTbR Controls IL-22 Protection Pathway in the GutLT on T and B cells did not show defects in IL-22 production.
Recent studies identified a heterogeneous population of ILCs
in the gut capable of producing IL-22 upon stimulation (Colonna,
2009; Sonnenberg et al., 2011a; Spits and Di Santo, 2011). In
particular, mucosal RORgt+NKp46+ cells were suggested as
a major source of IL-22 production in the small intestine lamina
propria (Luci et al., 2009; Sanos et al., 2009; Satoh-Takayama
et al., 2008). In contrast to RORgt+NKp46+ cells, LTi cells did
not produce IL-22 in the small intestine lamina propria from naive
mice (Luci et al., 2009; Sanos et al., 2009), although other studies
reported IL-22 expression also by LTi cells (Marchesi et al., 2009;
Sawa et al., 2010). It remains possible that cytokine production
by LTi cells might change under ongoing bacterial infection
conditions. A recent study reported that LTi cells in the IEL
compartment were, in fact, the major IL-22 producing cells after
C. rodentium infection (Sonnenberg et al., 2011b). Yet another
study suggested that DCs could also contribute significantly to
IL-22 levels soon after C. rodentium infection (Zheng et al.,50 Cell Host & Microbe 10, 44–53, July 21, 2011 ª2011 Elsevier Inc.2008). In contrast to this earlier study,
we found that DCs were not major
producers of IL-22 after infection.
However, we observed that DCs were in
close contact with IL-22-producing
RORgt+ cells in B cell follicles. Our results
using RORgt-GFP+/ reporter mice
showed that LTi cells were the predomi-
nant producers of IL-22 in the lamina
propria early after infection. Furthermore,
expression of IL-22 was greatly reduced
in LTi cells from Ltbr/mice, suggesting
that in the absence of LTbR signaling the
LTi cells are unable to produce IL-22 afterinfection. However, we found no intrinsic defect in IL-22 produc-
tion by lamina propria ILCs from Ltbr/ mice, since these cells
were able to produce IL-22 after in vitro stimulation with IL-23,
consistent with a recent report (Satoh-Takayama et al., 2011).
Our results are also consistent with a recent study (Sonnenberg
et al., 2011b) and extend our current understanding to suggest
that the LTi subset of ILCs actively participate in host defense
by regulating the IL-22 protection pathway in the gut.
ILCs produce various TNF family cytokines and chemokine
receptors, including TNF, LTa, LTb, LIGHT, TRANCE, CCR7,
CCR6, and CXCR5 (Luci et al., 2009; Marchesi et al., 2009;
Vonarbourg et al., 2010; Wang et al., 2010). Our study revealed
that a genetic inactivation of a single cytokine, surface LT
on RORgt+ ILCs, resulted in a dramatic defect in the production
of IL-22 by these cells, leading to a 100% mortality rate for
C. rodentium infection in mice. These results demonstrate that
LT expression in RORgt+ ILCs is critical for control of the IL-22
protection pathway in the gut.
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Figure 6. Proposed Model of How the IL-22 Pathway Defends
against Mucosal Bacterial Pathogens
LT expression by RORgt+ ILCs is necessary for IL-22 production following
invasion of mucosal bacterial pathogens. LT signaling by RORgt+ ILC
promotes the development of lymphoid follicles in the gut. Lymphoid follicles
provide the necessary microenvironment for interaction between innate
RORgt+ cells and DC. Interplay between RORgt+ ILCs and DCs promotes
IL-23 production byDCs that, in turn, activates IL-22 synthesis by RORgt+ cells
as a positive feedback loop. IL-22 stimulates IL-22R on epithelial cells, which
triggers production of antimicrobial proteins RegIIIg and RegIIIb to eliminate
mucosal bacterial pathogens.
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LTbR Controls IL-22 Protection Pathway in the GutIn contrast to LT, expression of LTbR on ILCs was dispensable
for IL-22-mediated protection, suggesting an indirect LT-depen-
dent mechanism of IL-22 production by RORgt+ ILCs. Remark-
ably, IL-22-producing cells were not randomly scattered in the
gut, but predominantly located in organized secondary lymphoid
tissues in the colon and closely interacted with DCs. By using
a conditional gene-targeting approach, we demonstrate that
LTbR signaling in DCs is important for IL-22 production and
bacterial clearance. We also cannot exclude the potential
contribution of LTbR signaling by other cells, in addition to
DCs, because IL-22 levels were only partially reduced in the
colon of CD11c-Ltbr/mice compared to Ltbr/mice. Ltbr/
mice havemultiple defects in the development of gut-associated
lymphoid tissues, which may additionally affect IL-22 production
independently of LTbR signaling in DCs.
Based on our results, we propose a model of regulation of
IL-22 production in the gut to control mucosal bacterial infection,
as shown in Figure 6. LT expression by RORgt+ ILCs is neces-
sary for IL-22 production following invasion of mucosal bacterial
pathogens. LT signaling by RORgt+ ILCs promotes the develop-
ment of lymphoid follicles in the gut. Lymphoid follicles provide
the necessary microenvironment for close interaction between
RORgt+ ILCs and DCs. Interplay between RORgt+ ILCs and
DCs then promotes IL-23 secretion byDCs that, in turn, activates
IL-22 production by RORgt+ cells as a positive feedback loop.
Since both LT (LTb2LTa1) and LTbR exist only as membrane-
bound molecules, DC and RORgt+ ILC interaction likely requires
direct cell contact. IL-22 activates IL-22R on epithelial cells,Cwhich leads to the production of antimicrobial proteins RegIIIg
and RegIIIb to eliminate the mucosal bacterial pathogen. Thus,
our study opens avenues to explore the role of ILC and DC coop-
eration in host defense and in pathogenesis of autoimmune
diseases.
It was recently proposed by several studies that host-protec-
tive functions of RORgt+ ILCs evolutionarily preceded the acqui-
sition of lymphoid tissue-inducing functions (Lane et al., 2009;
Sonnenberg et al., 2011b). However, our study suggests that
gut-associated lymphoid tissues provide an environment where
RORgt+ ILCs coordinate closely with cells of the adaptive
immune system. It is also possible that LT signaling by RORgt+
ILCs participates in themaintenance of gut-associated lymphoid
tissues. Therefore, the mechanism of interplay and coordination
of ILCs with components of the adaptive immune system will be
an exciting area of future research.
In animal models of colitis, expression of IL-22 by both innate
and adaptive immune cells regulates colon inflammation in both
DSS-induced and T cell-induced colitis models (Sugimoto et al.,
2008; Zenewicz et al., 2008). Other studies show that LT produc-
tion by B cells promotes colon inflammation in a DSS-induced
inflammation model (Jungbeck et al., 2008; Lochner et al.,
2011), while RORgt+ ILCs reduce colon inflammation in this
model (Sawa et al., 2011). In light of our results, it would be
important to determine whether LT from innate RORgt+ cells
can also participate in prevention of colon inflammation in
DSS-induced colitis and other models of colon inflammation.
Elevated IL-22 levels have been reported in IBD patients
(Ouyang, 2010). Although the role of IL-22 in IBD is complex,
most studies suggest a protective role for IL-22 in IBD, through
regulating epithelial barrier function, regeneration of epithelial
cells, and production of anti-bacterial proteins (Sonnenberg
et al., 2011a; Sugimoto et al., 2008; Zenewicz et al., 2008).
However, a pathogenic role for IL-22 has been shown in other
organs; for example, IL-22 promotes psoriasis (Ouyang, 2010).
Therefore, careful design of IL-22-modulating agents is required
for the development of potential therapeutic approaches. Our
data suggest that LTbR signaling regulates IL-22 production by
ILCs in the gut and that pharmacological manipulation of LTbR
signaling could represent a therapeutic avenue in autoimmune
diseases.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 and Rag1/ mice were purchased from Harland Teklad. Ltb/,
Tnfsf14/, and Ltbr/ mice were backcrossed onto C57BL/6 background
13, 11, or 10 generations, respectively, and maintained under specific path-
ogen-free conditions as described (Wang et al., 2010). Rorc/ (Eberl and Litt-
man,2004)micewerepurchased fromJacksonLaboratory.CD11c-Ltbr/and
RORgt-Ltbr/miceweregeneratedbycrossing LTbRfloxedmice (Wanget al.,
2010) with CD11c-Cre (Stranges et al., 2007) and RORgt-Cre (Eberl et al.,
2004), respectively. T,B-Ltb/ mice were described previously (Tumanov
et al., 2002; Tumanov et al., 2003). Animal care and use were in accordance
with institutional and National Institutes of Health guidelines, and all studies
were approved by the Institutional Animal Care and Use Committee of the
University of Chicago.
Citrobacter rodentium Infection
To induce bacterial colitis in mice, mice were orally gavaged with 2 3 109
colony-forming units (cfus) C. rodentium strain DBS100 (ATCC 51459;ell Host & Microbe 10, 44–53, July 21, 2011 ª2011 Elsevier Inc. 51
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LTbR Controls IL-22 Protection Pathway in the GutAmerican Type Culture Collection), as previously described (Zheng et al.,
2008). Briefly, mice were fasted for 8 hr before oral inoculation of
C. rodentium culture in a total volume of 0.2 ml per mouse. Bacteria were
prepared by shaking at 37C overnight in LB broth. Concentration was as-
sessed by measuring absorbance at OD600. Bacterial culture was serially
diluted and plated after each inoculation to confirm the cfus administered.
Body weight wasmeasured a day before and then frequently during the course
of the disease.
LTbR-Ig and Anti-LTbR Antibody Treatment
The LTbR-Ig used in this study has been previously described (Wang et al.,
2010). Briefly, cDNA encoding the extracellular domain of murine LTbR was
fused with the Fc portion of human IgG, transfected into BHK/VP16 cells,
and the supernatant was collected. The anti-LTbR agonistic antibody (3C8)
was kindly provided by C. Ware (La Jolla Institute for Allergy and Immunology,
La Jolla, CA).
Isolation of IELs, LPL Mononuclear Cells, and Epithelial Cells
from Mouse Colon
IELs, LPLs, and colonic epithelial cells were isolated as described (Wang et al.,
2010).
Tissue Collection, Histology, Histological Score, and cfu Counts
Colons from the mice were dissected and fixed in 10% neutral buffered
formalin. Paraffin-embedded tissue sections were stained with H&E to eval-
uate tissue pathology. Histological scoring was performed using a modified
scoring system described previously (Zheng et al., 2008). In brief, the presence
of rare inflammatory cells in the lamina propria were counted as: 0, no inflam-
matory cells; 1, confluence of inflammatory cells; 2, inflammatory cells extend-
ing into the submucosa; 3, transmural extension of the inflammatory cell
infiltrate. For epithelial damage, absence of mucosal damage was counted
as 0, discrete focal lymphoepithelial lesions were counted as 1, mucosal
erosion/ulceration was counted as 2, and a score of 3 was given for extensive
mucosal damage and extension through deeper structures of the bowel wall.
The two subscores were added and the combined histological score ranged
from 0 (no changes) to 6 (extensive). For cfu count, fecal samples were
collected and weighted, then homogenized in sterile phosphate-buffered
saline (PBS). Serially diluted homogenates were plated on MacConkey agar
plates (Sigma). C. rodentium colonies were identified as pink colonies after
overnight incubation at 37C. Spleens and livers were aseptically removed
and homogenized. Organ colonization was assessed as described for fecal
specimens.
Hydrodynamic IL-22 Delivery
Mice were restrained in conical restrainer with a heating element to dilate
blood vessels. 10 mg of IL-22-expressing plasmid (pRK-mIL-22, Genentech)
or control vector (pRK) were injected in the tail vein 6 hr after C. rodentium
infection in 1.6 ml of TransIT-EE Hydrodynamic Delivery Solution (MIR 5340,
Mirus Bio LLC) over a period of 3–5 s.
ELISA
Terminal colon pieces, 1 cm in length, were cut in small pieces and incubated
in 0.3 ml of RPMI 1640 medium containing 10% FCS, amphotericin, genta-
micin, penicillin, and streptomycin for 48 hr in tissue plates, as previously
described (Zheng et al., 2008). IL-22 in supernatants was measured by ELISA
(R&D Systems) according to the manufacturer’s recommendations.
Flow Cytometry and Antibodies
Flow cytometry analysis was performed on FACSCanto and FACSAria II (BD
Biosciences) instruments and analyzed using FlowJo software (Tree Star
Inc.). All antibodies were purchased from BD Biosciences or eBioscience.
Intracellular staining for IL-22 and RORgt was performed as described previ-
ously (Sawa et al., 2010).
RNA Isolation and Real-Time Reverse Transcriptase-PCR
RNA from cells or tissues was isolated using RNeasy Micro or Mini Kit
(QIAGEN). cDNA synthesis and real-time RT-PCR was performed as
described (Wang et al., 2010).52 Cell Host & Microbe 10, 44–53, July 21, 2011 ª2011 Elsevier Inc.Immunohistochemistry
Colons were isolated from mice and extensively washed in PBS, then fixed
for 1 hr in 4% (wt/vol) paraformaldehyde/PBS. After three washes in PBS,
paraformaldehyde-fixed organs were incubated in a 30% (wt/vol) sucrose/
PBS solution overnight. Fixed tissues were embedded in optimum cutting
temperature compound (Sakura Finetek) and frozen at 70C. Cryostat
sections, 6–8 mm in length, were stained with IL-22 (Alexa 555-conjugated,
clone 8E11, Genentech) and RORgt (hamster polyclonal antibody), as previ-
ously described (Eberl et al., 2004; Zheng et al., 2008). After being stained,
slides were dried, mounted with ProLong Gold (Invitrogen), and examined
with a Nikon A1 confocal microscope (Nikon, Inc.) or Zeiss Axiovert 200M
microscope (Carl Zeiss, Inc.). Images were processed with NIH ImageJ
v.1.42 software.
Statistical Analysis
Comparisons of data were analyzed by two-tailed Student’s t test using
GraphPad Prism 5.0 program. Data from such experiments are presented as
mean values ± SEM; p < 0.05 was considered significant. For survival curves,
statistics were done using the log rank (Mantel-Cox) test.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and may be found with this
article online at doi:10.1016/j.chom.2011.06.002.
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